APA (7th ed.) Citation

Alanteet, A., Attia, H., Alfayez, M., Mahmood, A., Alsaleh, K., & Alsanea, S. (2024). Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway. Saudi pharmaceutical journal, 32(1), 101923. https://doi.org/10.1016/j.jsps.2023.101923

Chicago Style (17th ed.) Citation

Alanteet, Alaa, Hala Attia, Musaed Alfayez, Amer Mahmood, Khalid Alsaleh, and Sary Alsanea. "Liraglutide Attenuates Obese-associated Breast Cancer Cell Proliferation via Inhibiting PI3K/Akt/mTOR Signaling Pathway." Saudi Pharmaceutical Journal 32, no. 1 (2024): 101923. https://doi.org/10.1016/j.jsps.2023.101923.

MLA (9th ed.) Citation

Alanteet, Alaa, et al. "Liraglutide Attenuates Obese-associated Breast Cancer Cell Proliferation via Inhibiting PI3K/Akt/mTOR Signaling Pathway." Saudi Pharmaceutical Journal, vol. 32, no. 1, 2024, p. 101923, https://doi.org/10.1016/j.jsps.2023.101923.